The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genetic determinants of toxicity and quality-of-life (QOL) outcomes for SBRT in Asian prostate cancer.
 
Janice Ser Huey Tan
No Relationships to Disclose
 
Sheena Xue Fei Tan
No Relationships to Disclose
 
Youquan Li
No Relationships to Disclose
 
Jeffrey Kit Loong Tuan
No Relationships to Disclose
 
Terence Wee Kiat Tan
No Relationships to Disclose
 
Michael Lian Chek Wang
No Relationships to Disclose
 
Kae Jack Tay
No Relationships to Disclose
 
Lui Shiong Lee
No Relationships to Disclose
 
Jonathan Yi Hui Teh
No Relationships to Disclose
 
Melvin Lee Kiang Chua
Stock and Other Ownership Interests - Merrimack (I); Pluristem Therapeutics (I); Varian Medical Systems
Honoraria - AstraZeneca; Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Ferring; Varian Medical Systems
Research Funding - Ferring; GenomeDx; Medlever (Inst); Medlever (Inst); Varian Medical Systems
Travel, Accommodations, Expenses - Apollo; Ferring; Varian Medical Systems